Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
---|
01/23/2014 | WO2013082345A8 Aryl dihydropyridinones and piperidinones as mgat2 inhibitors |
01/23/2014 | US20140024815 Dendrimers with interior and exterior functionalities comprising of azide or alkyne groups for post-functionalization by huisgen click cycloaddition |
01/22/2014 | EP2687516A1 Inhibitors of C-FMS Kinase |
01/22/2014 | CN103524468A Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein |
01/21/2014 | US8633326 Method for preparing taxane derivatives |
01/21/2014 | US8633236 Compounds, compositions and methods |
01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
01/16/2014 | WO2014010824A1 Heterocyclic compound and organic electronic element containing same |
01/16/2014 | WO2014010823A1 Heterocyclic compound and organic electronic element containing same |
01/16/2014 | WO2014010737A1 Oxime-substituted amide compound and pest control agent |
01/16/2014 | WO2014008992A1 Pyrimidine pyrazolyl derivatives |
01/16/2014 | US20140016179 Pigment-based inks |
01/15/2014 | CN103517899A Chromene compound |
01/15/2014 | CN103509647A Method for preparing silybum marianum oil rich in silymarin |
01/15/2014 | CN103509044A Beraprost sodium intermediates and preparation method thereof |
01/15/2014 | CN103508981A New piperazine derivative and medical applications |
01/14/2014 | US8629197 Chemically patterned hydrogels, manufacture and use thereof |
01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
01/09/2014 | US20140011845 Chemical compounds |
01/09/2014 | US20140007497 Biorefining compounds and organocatalytic upgrading methods |
01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
01/08/2014 | EP2682393A1 Inhibitors of HCV NS5A comprising a bicyclic core. |
01/08/2014 | CN102239157B Diolefin compound, epoxy resin, curable resin composition and cured product |
01/03/2014 | WO2014004064A1 Fungicidal heterocyclic carboxamides |
01/03/2014 | WO2014002105A1 Compounds for the treatment of dyslipidemia and other diseases |
01/03/2014 | CA2877862A1 Fungicidal heterocyclic carboxamides |
01/01/2014 | CN103483291A 4,5-diaryl-1,3-selenazole compound, preparation method and use thereof |
12/31/2013 | CA2544678C Modulators of cellular adhesion |
12/27/2013 | WO2013192352A1 Antibacterial agents: aryl myxopyronin derivatives |
12/27/2013 | WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment |
12/25/2013 | EP2676965A1 Aryl glycoside compound, preparation method and use thereof |
12/25/2013 | EP2675798A1 Novel benzodioxole piperazine compounds |
12/25/2013 | CN103467463A Lignin derivatives as well as preparation method and use thereof |
12/25/2013 | CN103467423A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
12/25/2013 | CN103467282A Synthesis method of polysubstitution naphthol and derivative of polysubstitution naphthol |
12/25/2013 | CN102311418B Preparation method for benzodihydropyran compound |
12/24/2013 | US8613909 Cinnamic acid-based oligomers and uses thereof |
12/19/2013 | WO2013188381A1 Pyridinone and pyridazinone derivatives |
12/19/2013 | WO2013188253A1 Monoallyl, monoglycidyl ethers and bisglycidyl ethers of isohexides |
12/19/2013 | CA2875016A1 Pyridinone and pyridazinone derivatives |
12/18/2013 | EP2493885B1 Polyketide molecules as anticancer agents |
12/18/2013 | EP2440204B1 Nicotinamide compounds useful as kinase modulators |
12/18/2013 | CN103450165A 2,3-dehydrosilybin derivative, and preparation method and use thereof |
12/18/2013 | CN103450129A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
12/17/2013 | US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer |
12/12/2013 | WO2013182263A1 Phenanthrene compounds for organic electronic devices |
12/11/2013 | EP2671876A2 Pyrazine derivatives and their use as protein kinase inhbitors |
12/11/2013 | CN103443097A Fused dihydrofurans as GPR119 modulators for the treatment of diabetes, obesity and related disorders |
12/11/2013 | CN103435581A Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof |
12/11/2013 | CN102161657B Mangiferin crystal I and preparation method thereof |
12/10/2013 | US8604077 Ketal compounds from polyols and oxocarboxylates |
12/05/2013 | WO2013180375A1 Composition and cured article comprising inorganic particles and epoxy compound having alkoxysilyl group, use for same, and production method for epoxy compound having alkoxysilyl group |
12/05/2013 | US20130324577 Bicyclic compound and use thereof for medical purposes |
12/05/2013 | US20130324525 Substituted heterocyclic compounds |
12/04/2013 | EP2669279A1 Bicyclic compound and use thereof for medical purposes |
12/04/2013 | EP2668181A1 Pyrazole compounds as crth2 antagonists |
12/04/2013 | CN103420992A Method for preparing ketoside from gardenia |
12/04/2013 | CN102219782B Method for extracting and separating viterxin and isovitexin from natural product |
12/04/2013 | CN101646664B Furanone compounds |
12/03/2013 | US8597706 Method for synthesizing 2-acetyl-1-pyrroline, stable ketal precursors thereof, and isotopically marked analogs |
11/28/2013 | WO2013177243A1 Sulfilimine and sulphoxide methods for producing festinavir |
11/28/2013 | WO2013175388A1 Novel ring-substituted n-pyridinyl amides as kinase inhibitors |
11/28/2013 | WO2013174485A1 SUBSTITUTED ß-AMINO ACID DERIVATIVES AS CXCR3 RECEPTOR ANTAGONISTS |
11/27/2013 | EP2666769A1 Substituted B-amino acid derivatives as CXCR3 receptor antagonist |
11/27/2013 | EP2665719A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders |
11/27/2013 | CN103408602A Separation and preparation method for four glycoside chemical reference substances in Tibetan capillary artemisia |
11/27/2013 | CN103408539A Production method of high-purity silibinin |
11/27/2013 | CN103408538A Method for extracting silymarin |
11/26/2013 | US8592057 Organic electroluminescence element, new compound for the same, display device and lighting device using the same |
11/26/2013 | CA2759399C Inhibitors of the renal outer medullary potassium channel |
11/21/2013 | WO2013171641A1 Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1 |
11/21/2013 | WO2013171092A1 Plant growth regulating compounds |
11/21/2013 | US20130310288 Ketal compounds and uses thereof |
11/20/2013 | EP2663558A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
11/20/2013 | EP2346834B1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives |
11/20/2013 | CN103402960A Process for the preparation of alditol acetals |
11/20/2013 | CN103402959A Method of making diacetal compound in aqueous medium |
11/20/2013 | CN103402515A Sgc stimulators |
11/20/2013 | CN103396383A Preparation method of chiral epoxy compound |
11/19/2013 | CA2746307C Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors |
11/14/2013 | WO2013170155A2 Methods of purifying and identifying the presence of and levels of procyanidin oligomeric compounds |
11/14/2013 | US20130303601 Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents |
11/14/2013 | US20130303544 Benzopyrone estrogen receptor regulator |
11/13/2013 | EP2661432A1 Pyrrolidine derivatives as nk3 antagonists |
11/13/2013 | CN103387587A Preparation method for entecavir intermediate |
11/13/2013 | CN101974026B Allyl acyl silicon compound with two chiral centers in positions alpha and beta, preparation method and application |
11/13/2013 | CN101883764B Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
11/13/2013 | CN101679279B Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists |
11/07/2013 | WO2013164321A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators |
11/07/2013 | US20130296583 Nebivolol and its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol |
11/07/2013 | US20130296379 Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-Methylpyridin-2-yl)Benzoic Acid |
11/06/2013 | EP2660240A1 Benzopyrone estrogen receptor regulator |
11/06/2013 | EP2658855A2 Novel polyketide compounds and methods of making same |
11/06/2013 | EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
11/06/2013 | CN103384712A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
11/06/2013 | CN103384666A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
11/06/2013 | CN103384662A Novel 1,2-bis-sulfonamide derivatives as chemokine receptor modulators |
11/06/2013 | CN103382203A Puerarin derivative and synthetic method and application thereof |
11/06/2013 | CN103382196A (E)-1-(8-benzopyranyl)-2-allyl-1-one and its analogues, and use thereof |
11/06/2013 | CN102229578B Preparation method of 2-arylamino-1,3,4-oxadiazole compound |